Drug intelligence / Profile preview

siXIAP

Development stage
Preclinical
Lead developer
University of Illinois
Modality
Chemically Modified siRNA → Small Interfering RNA (siRNA) → Small RNA Therapeutics → RNA Therapeutics → Nucleic Acid Therapeutics, Conjugated siRNA → Small Interfering RNA (siRNA) → Small RNA Therapeutics → RNA Therapeutics → Nucleic Acid Therapeutics
01

Overview

siXIAP is a small interfering RNA (siRNA) designed to silence the expression of the X-linked inhibitor of apoptosis protein (XIAP), also known as BIRC4. XIAP is a potent endogenous inhibitor of apoptosis that functions by binding to and inhibiting initiator caspase-9 and effector caspases-3 and -7. In many cancers, including glioblastoma, XIAP is overexpressed, contributing to tumor cell survival, invasion, and resistance to chemotherapy and radiotherapy. By targeting XIAP mRNA for degradation, siXIAP reduces the levels of the XIAP protein, thereby lowering the threshold for apoptosis and sensitizing cancer cells to cell death triggers. Research has demonstrated that siXIAP can induce TNF-alpha-mediated apoptosis, lead to the loss of mitochondrial membrane potential, and inhibit the proliferation of malignant glioma cells in both in vitro and xenograft models.

Other names
XIAP siRNAsiRNA of XIAPXIAP-targeting siRNA
02

Targets

XIAPAGO2 (Argonaute RISC catalytic component 2)Innate immune RNA sensors

Beyond the preview

Go deeper on siXIAP.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Full profile access

Follow clinical development from study design and recruitment through results.

  • Trial phase
  • Status
  • Readouts

Indications & development

Full profile access

Explore development by indication, patient population, and geography.

  • Indications
  • Development status
  • Countries

Licensing & deals

Full profile access

Trace asset ownership, licensing agreements, and commercial partnerships.

  • Partners
  • Deal terms
  • Milestones

Patents & exclusivity

Full profile access

Explore the patent landscape and regulatory exclusivity around an asset.

  • Patents
  • Expiration dates
  • Exclusivity

Competitive landscape

Full profile access

Compare development programs by target, modality, and indication.

  • Competing assets
  • Targets
  • Development stage

Research & analysis

Full profile access

Connect source evidence and development news to your research questions.

  • Publications
  • News
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on siXIAP.

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call